Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Model uncertainty and model averaging in the estimation of infectious doses for microbial pathogens.

Moon H, Kim SB, Chen JJ, George NI, Kodell RL.

Risk Anal. 2013 Feb;33(2):220-31. doi: 10.1111/j.1539-6924.2012.01853.x. Epub 2012 Jun 9.

PMID:
22681783
[PubMed - indexed for MEDLINE]
2.

Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo.

Schmidt PJ, Pintar KD, Fazil AM, Topp E.

Risk Anal. 2013 Sep;33(9):1677-93. doi: 10.1111/risa.12006. Epub 2013 Jan 11.

PMID:
23311599
[PubMed - indexed for MEDLINE]
3.

Potential uncertainty reduction in model-averaged benchmark dose estimates informed by an additional dose study.

Shao K, Small MJ.

Risk Anal. 2011 Oct;31(10):1561-75. doi: 10.1111/j.1539-6924.2011.01595.x. Epub 2011 Mar 9.

PMID:
21388425
[PubMed - indexed for MEDLINE]
4.

Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.

Cox LA Jr.

Environ Health Perspect. 1996 Dec;104 Suppl 6:1413-29.

PMID:
9118928
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Properties of model-averaged BMDLs: a study of model averaging in dichotomous response risk estimation.

Wheeler MW, Bailer AJ.

Risk Anal. 2007 Jun;27(3):659-70.

PMID:
17640214
[PubMed - indexed for MEDLINE]
6.

Model averaging in microbial risk assessment using fractional polynomials.

Namata H, Aerts M, Faes C, Teunis P.

Risk Anal. 2008 Aug;28(4):891-905. doi: 10.1111/j.1539-6924.2008.01063.x. Epub 2008 Jun 28.

PMID:
18564995
[PubMed - indexed for MEDLINE]
7.

Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.

Zhu Y, Wang T, Jelsovsky JZ.

Risk Anal. 2007 Apr;27(2):447-65.

PMID:
17511711
[PubMed - indexed for MEDLINE]
8.

Model averaging using the Kullback information criterion in estimating effective doses for microbial infection and illness.

Moon H, Kim HJ, Chen JJ, Kodell RL.

Risk Anal. 2005 Oct;25(5):1147-59.

PMID:
16297221
[PubMed - indexed for MEDLINE]
9.

Case studies in Bayesian microbial risk assessments.

Kennedy MC, Clough HE, Turner J.

Environ Health. 2009 Dec 21;8 Suppl 1:S19. doi: 10.1186/1476-069X-8-S1-S19.

PMID:
20102586
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A diversity index for model space selection in the estimation of benchmark and infectious doses via model averaging.

Kim SB, Kodell RL, Moon H.

Risk Anal. 2014 Mar;34(3):453-64. doi: 10.1111/risa.12104. Epub 2013 Aug 26.

PMID:
23980524
[PubMed - indexed for MEDLINE]
11.

Assessing the uncertainty in QUANTEC's dose-response relation of lung and spinal cord with a bootstrap analysis.

Wedenberg M.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):795-801. doi: 10.1016/j.ijrobp.2013.06.2040. Epub 2013 Aug 14.

PMID:
23953634
[PubMed - indexed for MEDLINE]
12.

Quantification of variability and uncertainty for censored data sets and application to air toxic emission factors.

Zhao Y, Frey HC.

Risk Anal. 2004 Aug;24(4):1019-34.

PMID:
15357825
[PubMed - indexed for MEDLINE]
13.

A Monte Carlo maximum likelihood method for estimating uncertainty arising from shared errors in exposures in epidemiological studies of nuclear workers.

Stayner L, Vrijheid M, Cardis E, Stram DO, Deltour I, Gilbert SJ, Howe G.

Radiat Res. 2007 Dec;168(6):757-63.

PMID:
18088178
[PubMed - indexed for MEDLINE]
14.

Determination of a site-specific reference dose for methylmercury for fish-eating populations.

Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T, Clewell HJ, Gribben K, Crump K.

Toxicol Ind Health. 2000 Nov;16(9-10):335-438. Review.

PMID:
11762928
[PubMed - indexed for MEDLINE]
15.

Calculation of out-of-field dose distribution in carbon-ion radiotherapy by Monte Carlo simulation.

Yonai S, Matsufuji N, Namba M.

Med Phys. 2012 Aug;39(8):5028-39. doi: 10.1118/1.4736823.

PMID:
22894428
[PubMed - indexed for MEDLINE]
16.

A comparison of three methods for integrating historical information for Bayesian model averaged benchmark dose estimation.

Shao K.

Environ Toxicol Pharmacol. 2012 Sep;34(2):288-96. doi: 10.1016/j.etap.2012.05.002. Epub 2012 May 14.

PMID:
22647377
[PubMed - indexed for MEDLINE]
17.

Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.

Shao K, Gift JS.

Risk Anal. 2013 Jun 11. doi: 10.1111/risa.12078. [Epub ahead of print]

PMID:
23758102
[PubMed - as supplied by publisher]
18.

Incorporating model uncertainties along with data uncertainties in microbial risk assessment.

Kang SH, Kodell RL, Chen JJ.

Regul Toxicol Pharmacol. 2000 Aug;32(1):68-72.

PMID:
11029270
[PubMed - indexed for MEDLINE]
19.

Proof of concept and dose estimation with binary responses under model uncertainty.

Klingenberg B.

Stat Med. 2009 Jan 30;28(2):274-92. doi: 10.1002/sim.3477.

PMID:
19012269
[PubMed - indexed for MEDLINE]
20.

Monotonic Bayesian semiparametric benchmark dose analysis.

Wheeler M, Bailer AJ.

Risk Anal. 2012 Jul;32(7):1207-18. doi: 10.1111/j.1539-6924.2011.01786.x. Epub 2012 Mar 2.

PMID:
22385024
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk